Показано 0 из 0
Дата |
---|
22:27 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
7.68
|
7.72
|
7.75
|
7.5253
|
7.825
|
7.71
|
|
|
2 575 426.02
|
4 162.00
|
7.78
|
8.16
|
8.18
|
7.6016
|
8.18
|
7.73
|
|
|
1 732 914.91
|
3 488.00
|
7.72
|
8.49
|
8.20
|
7.81
|
8.26
|
8.00
|
|
|
3 645 193.33
|
5 636.00
|
8.01
|
9.00
|
8.61
|
8.17
|
8.76
|
8.21
|
|
|
1 670 065.52
|
2 924.00
|
8.45
|
8.60
|
8.91
|
8.4501
|
8.91
|
8.50
|
|
|
2 077 021.93
|
3 802.00
|
8.30
|
8.60
|
8.57
|
8.515
|
8.88
|
8.60
|
|
|
879 422.35
|
2 151.00
|
8.32
|
8.45
|
8.60
|
8.2703
|
8.605
|
8.50
|
|
|
1 720 984.56
|
2 442.00
|
8.55
|
8.70
|
8.93
|
8.49
|
9.123
|
8.50
|
|
|
1 689 329.81
|
2 853.00
|
8.92
|
9.00
|
9.10
|
8.8114
|
9.2899
|
8.92
|
|
|
1 868 621.04
|
2 940.00
|
8.80
|
9.55
|
8.35
|
8.35
|
9.19
|
9.10
|
|
|
1 583 727.83
|
1 922.00
|
Outlook Therapeutics, Inc., formerly Oncobiologics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, manufacturing, and commercializing complex biosimilar therapeutics in immunology and oncology disease areas.